ObjectiveTo investigate the prognostic value of local therapy (LT) in cN1M0 prostate cancer (PCa).MethodsPatients diagnosed with cN1M0 PCa were extracted from the surveillance, epidemiology, and end results (SEER) database. Kaplan-Meier (KM) curve was used to compare the survival outcomes between patients treated with and without LT. Further, among patients receiving LT, KM analysis was also applied to investigate the survival differences in patients with radical prostatectomy (RP) and radiation therapy (RT). Propensity score matching (PSM) analysis was performed to balance the basic characteristics of patients in each group and make it comparable when exploring the survival impact of different treatment types. Finally, uni- and multivariab...
Context: There is uncertainty regarding the oncologic effectiveness and the survival advantage of lo...
2015-07-16Purpose: To assess survival following radical prostatectomy (RP), intensity modulated radi...
CONTEXT There is uncertainty regarding the oncologic effectiveness and the survival advantage of ...
ObjectiveTo investigate the prognostic value of local therapy (LT) in cN1M0 prostate cancer (PCa).Me...
ObjectiveTo investigate the prognostic value of local therapy (LT) in cN1M0 prostate cancer (PCa).Me...
ObjectiveTo investigate the prognostic value of local therapy (LT) in cN1M0 prostate cancer (PCa).Me...
ObjectiveTo investigate the prognostic value of local therapy (LT) in cN1M0 prostate cancer (PCa).Me...
ObjectiveTo investigate the prognostic value of local therapy (LT) in cN1M0 prostate cancer (PCa).Me...
ObjectiveTo investigate the prognostic value of local therapy (LT) in cN1M0 prostate cancer (PCa).Me...
ObjectiveTo investigate the prognostic value of local therapy (LT) in cN1M0 prostate cancer (PCa).Me...
ObjectiveTo investigate the prognostic value of local therapy (LT) in cN1M0 prostate cancer (PCa).Me...
BACKGROUND: The role of local treatment (LT) in patients with metastatic prostate cancer (mPCa) at d...
BACKGROUND: Treatment of the primary, termed local therapy (LT), may improve survival in metastatic ...
UNLABELLED: A recent study observed a survival benefit in men diagnosed with metastatic prostate can...
BACKGROUND: There is limited evidence supporting the use of local treatment (LT) for prostate cancer...
Context: There is uncertainty regarding the oncologic effectiveness and the survival advantage of lo...
2015-07-16Purpose: To assess survival following radical prostatectomy (RP), intensity modulated radi...
CONTEXT There is uncertainty regarding the oncologic effectiveness and the survival advantage of ...
ObjectiveTo investigate the prognostic value of local therapy (LT) in cN1M0 prostate cancer (PCa).Me...
ObjectiveTo investigate the prognostic value of local therapy (LT) in cN1M0 prostate cancer (PCa).Me...
ObjectiveTo investigate the prognostic value of local therapy (LT) in cN1M0 prostate cancer (PCa).Me...
ObjectiveTo investigate the prognostic value of local therapy (LT) in cN1M0 prostate cancer (PCa).Me...
ObjectiveTo investigate the prognostic value of local therapy (LT) in cN1M0 prostate cancer (PCa).Me...
ObjectiveTo investigate the prognostic value of local therapy (LT) in cN1M0 prostate cancer (PCa).Me...
ObjectiveTo investigate the prognostic value of local therapy (LT) in cN1M0 prostate cancer (PCa).Me...
ObjectiveTo investigate the prognostic value of local therapy (LT) in cN1M0 prostate cancer (PCa).Me...
BACKGROUND: The role of local treatment (LT) in patients with metastatic prostate cancer (mPCa) at d...
BACKGROUND: Treatment of the primary, termed local therapy (LT), may improve survival in metastatic ...
UNLABELLED: A recent study observed a survival benefit in men diagnosed with metastatic prostate can...
BACKGROUND: There is limited evidence supporting the use of local treatment (LT) for prostate cancer...
Context: There is uncertainty regarding the oncologic effectiveness and the survival advantage of lo...
2015-07-16Purpose: To assess survival following radical prostatectomy (RP), intensity modulated radi...
CONTEXT There is uncertainty regarding the oncologic effectiveness and the survival advantage of ...